Acupuncture and Fatty liver

The Effects of Acupuncture with Weight Loss Diet on Metabolic Parameters in Patients with Non-Alcoholic Fatty Acid Liver: Randomized Controlled Single-Blinded Clinical Trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110314006065N5

Enrollment

Registered

2025-03-01

Start date

2025-04-05

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Alcoholic Fatty Liver Disease (NAFLD). Other diseases of liver

Interventions

Intervention 1: Intervention group: The participants will receive acupuncture (twice a week) along with a weight loss diet. The individuals involved in this treatment will be monitored by a nutrition

Eligibility

Sex/Gender

All

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with non-alcoholic fatty liver disease (NAFLD) with grades 2 or 3

Exclusion criteria

Exclusion criteria: Individuals with chronic thyroid disorders Autoimmune disorders Various malignancies Liver diseases other than non-alcoholic fatty liver disease, including types of hepatitis (A, B, C) Wilson's disease Crohn's disease Uncontrolled diabetes Hemochromatosis Alcohol consumers and hepatotoxic substances Adherence to traditional treatment methods including the use of herbal medicine for treating NAFLD Pregnant or breastfeeding women

Design outcomes

Primary

Measure	Time frame
Liver enzymes. Timepoint: Baseline and the end (8th weeks). Method of measurement: Enzymetic.	—

Secondary

Measure	Time frame
Fasting blood sugar. Timepoint: Baseline and End (8th week). Method of measurement: Enzymatic.;Total cholesterol (TC). Timepoint: Baseline and End (8th week). Method of measurement: Enzymatic.;Triglyceride (TG). Timepoint: Baseline and End (8th week). Method of measurement: Enzymatic.;Low lipoprotein density cholesterol (LDL-C). Timepoint: Baseline and End (8th week). Method of measurement: Enzymatic.;High-density lipoprotein cholesterol (HDL-C). Timepoint: Baseline and End (8th week). Method of measurement: Enzymatic.;Weight. Timepoint: Baseline and End (8th week). Method of measurement: Scale.;Body mass index (BMI). Timepoint: Baseline and End (8th week). Method of measurement: Dividing weight to square of height in meter.	—

Measure

Time frame

Fasting blood sugar. Timepoint: Baseline and End (8th week). Method of measurement: Enzymatic.;Total cholesterol (TC). Timepoint: Baseline and End (8th week). Method of measurement: Enzymatic.;Triglyceride (TG). Timepoint: Baseline and End (8th week). Method of measurement: Enzymatic.;Low lipoprotein density cholesterol (LDL-C). Timepoint: Baseline and End (8th week). Method of measurement: Enzymatic.;High-density lipoprotein cholesterol (HDL-C). Timepoint: Baseline and End (8th week). Method of measurement: Enzymatic.;Weight. Timepoint: Baseline and End (8th week). Method of measurement: Scale.;Body mass index (BMI). Timepoint: Baseline and End (8th week). Method of measurement: Dividing weight to square of height in meter.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazli Namazi

Tehran University of Medical Sciences

nazli.namazi@yahoo.com+98 21 8863 1297

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026